| 英文别名 |
5-Methylcytidine;Cytidine,5-methyl-;5-Methyl-cytidin;5-methyl-cytidine;Cytidine,5-Methyl;NSC 363933;3: PN: US20060035254 PAGE: 63 claimed sequence;Cytidine, 5-methyl-;TL9PB228DC;ZAYHVCMSTBRABG-JXOAFFINSA-N;4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one;AK145432;5-Methyl-D-cytidine;Adenosine receptor agonist, 13;BDBM200216;GE4109;AM839;s6138;SB35398;AM83948;4;SCHEMBL41572;AC-32357;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidin-2-one;CHEBI:20607;C74035;A815317;DTXSID401016977;EINECS 218-390-8;CS-0061684;2140-61-6;DS-8104;4-AMINO-1-.BETA.-D-ARABINOFURANOSYL-5-METHYLPYRIMIDIN-2(1H)-ONE;UNII-TL9PB228DC;BRD-K65963527-001-01-8;NSC-363933;MFCD00006548;5-Methylcytidine, >=99%;PD018047;AKOS015896918;4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2-dihydropyrimidin-2-one;AKOS015841917;CYTARABINE IMPURITY I [EP IMPURITY];4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one;NS00049274;CHEMBL72086;Q238546;M1931;HY-113135;J-700100;4-Amino-5-methyl-1-ss-D-ribofuranosylpyrimidin-2(1H)-one; 5-Methylcytidine; Cytarabine Imp. G (EP);4-Amino-5-methyl-1-ss-D-ribofuranosylpyrimidin-2(1H)-one; 5-Methylcytidine; Cytarabine Imp. G (EP);1ST158246;1ST158246 |
